Skip to main content
SpringerLink
Log in

Distribution, Incidence, and Prognosis in Neuroendocrine Tumors: a Population Based Study from a Cancer Registry

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Neuroendocrine tumors are considered rare tumors: recently an increased incidence and an improvement in survival were described. We explore distribution, incidence and survival of neuroendocrine tumors using population based registry data. We extracted from the Tuscan Cancer Registry neuroendocrine tumors from 1985–2005, and we evaluated distribution, incidence ad survival according to sex, site of tumor, age and stage at diagnosis. 455 cases of neuroendocrine tumors were identified. The overall incidence increased over the study period from 0.7 per 100,000 per year to 1.6 among men (APC +3.6) and from 0.3 to 2.1 among women (APC +4.8). The anatomic distribution of tumors was lung 25.7%, small intestine 23.5%, appendix 10.9%, colon 10.3%, pancreas 9.4%, stomach 7.4%, and rectum 5.2%. Neuroendocrine tumors were more frequent among males and incidence rate increased with age. We observed increased incidence of neuroendocrine tumors, while survival did not change over time. Prognosis varied with age, stage and localization; females had better survival than males. The increase number of neuroendocrine tumors may be due, at least in part, to better registration and to improvement of diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AKC (2008) Neuroendocrine tumor epidemiology. Contrasting Norway and North America. Cancer 113:2655–2664

    Article  PubMed  Google Scholar 

  2. Pape UF, Jann H, Muller-Nordhorn J, Bockelbrink A, Willich SN, Koch M, Rocken C, Rindi G, Wiedenmann B (2008) Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113:256–265

    Article  PubMed  Google Scholar 

  3. Oberg KE (2010) Gastrointestinal neuroendocrine tumors. Ann Oncol 21(Suppl7):vii72–vii80

    Article  PubMed  Google Scholar 

  4. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35.825 cases in the United States. J Clin Oncol 26:3063–3072

    Article  PubMed  Google Scholar 

  5. Ploeckinger U, Kloeppel G, Wiedenmann B, Lohmann R, Representatives of 21 German NET Centers (2009) The German NET-Registry: an audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology 90:349–363

    Article  PubMed  CAS  Google Scholar 

  6. Kloppel G, Rindi G, Anlauf M, Perren A, Komminoth P (2007) Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 451(suppl 1):S9–S27

    Article  PubMed  Google Scholar 

  7. Faggiano A, Mansueto G, Ferolla P, Milone F, del Basso de Caro ML, Lombardi G, Colao A, De Rosa G (2008) Diagnostic and prognostic implication of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Investig 31(3):216–223

    CAS  Google Scholar 

  8. Modlin IM, Lye KD (2003) Kidd M” A 5-decade analysis of 13.715 carcinoid tumors”. Cancer 97:934–959

    Article  PubMed  Google Scholar 

  9. Hemminki K, Li X (2001) Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92:2204–2210

    Article  PubMed  CAS  Google Scholar 

  10. Moran CA, Suster S, Coppola D (2009) Neuroendocrine carcinomas of the lung. A critical analysis. Am J Clin Pathol 131:206–221

    Article  PubMed  Google Scholar 

  11. Ni SJ, Sheng WQ, Du X (2010) Pathologic research update of colorectal neuroendocrine tumors. World J Gastroenterol 16(14):1713–1719

    Article  PubMed  CAS  Google Scholar 

  12. Rekhtman N (2010) Neuroendocrine tumors of the lung. An update. Arch Pathol Lab Med 134:1628–1638

    PubMed  Google Scholar 

  13. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herde WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A (2008) Gastroenetropancreatic neuroendocrine tumors. Lancet Oncol 9:61–72

    Article  PubMed  CAS  Google Scholar 

  14. Kocha W, Maroun J, Kennecke H, Law C, Metrakos P, Ouellet JF, Reid R, Rowsell C, Shah A, Singh S, Van Uum S, Wong R (2010) Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumors: a revised statement from a Canadian National Expert Group. Curr Oncol 17(3):49–64

    Article  PubMed  CAS  Google Scholar 

  15. Gustafsson BI, Siddique L, Chan A, Dong M, Drozdov I, Kidd M, Modlin IM (2008) Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973–2004, and current diagnosis and therapy. Int J Oncol 33:1121–1131

    PubMed  Google Scholar 

  16. Bertino EM, Confer PD, Colonna JE, Ross P, Otterson GA (2009) Pulmonary neuroendocrine/carcinoid tumors. Cancer 115:4434–4441

    Article  PubMed  Google Scholar 

  17. Halfdanarson TR, Rabe KG, Rubin J, Petersen GM (2008) Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol 19:1727–1733

    Article  PubMed  CAS  Google Scholar 

  18. Luke C, Price T, Towsend A, Karapetis C, Kotasek D, Singhal N, Racey E, Roder D (2010) Epidemiology of neuroendocrine cancers in an Australian population. Cancer Causes Control 21(6):931–938

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical and Descriptive Epidemiology Unit, Institute for Study and Cancer Prevention (ISPO), Via di San Salvi,12, Florence, 50135, Italy

    Adele Caldarella, Emanuele Crocetti & Eugenio Paci

Authors
  1. Adele Caldarella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuele Crocetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugenio Paci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adele Caldarella.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caldarella, A., Crocetti, E. & Paci, E. Distribution, Incidence, and Prognosis in Neuroendocrine Tumors: a Population Based Study from a Cancer Registry. Pathol. Oncol. Res. 17, 759–763 (2011). https://doi.org/10.1007/s12253-011-9382-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-011-9382-y

Keywords

Search

Navigation